impact on neurological comorbidities

In this article the authors aimed to explore the interaction between COVID-19 and Alzheimer's disease by integrating bioinformatics to find the biomarkers which lead to AD occurrence and development with COVID-19 and provide early intervention.

In this article the authors aimed to explore the impact of the pandemic on community-dwelling individuals with mild-to-moderate dementia and compare responses with pre-pandemic data.

The purpose of this systematic review study was to investigate the epidemic effect of COVID-19 on increasing the prevalence of mental disorders such as depression, anxiety, and sleep disorders in people with epilepsy.

The aim of the study was to determine the association between previous stroke and mortality after coronavirus disease 2019 (COVID-19) according to sex, age groups, and stroke subtypes.

The goal of this study is to update the pooled prevalence of COVID-19 infection in patients with Parkinson's disease.

CogEx is an international, multicentre MS dual-intervention (cognitive rehabilitation, aerobic exercise) randomized, controlled rehabilitation trial confined to people with progressive disease.

This retrospective observational study aims to explore associations between PM2.5 and COVID-19 severity amongst PwMS.

The aim of this study is to compare COVID-19–related outcomes collected in an Italian cohort of patients with MS with the outcomes expected in the age- and sex-matched Italian population.

The objective of this study was to investigate the impact of COVID-19 on children receiving immunosuppressive therapies for neuroimmunologic disorders.

In this article the authors aimed to evaluate the impact of the COVID-19 pandemic on patient-reported health outcomes after hospital admission for acute stroke.

Case series/case reports (Indigo) In March 2020, the United Kingdom Multiple Sclerosis Register (UKMSR) established an electronic case return form, designed collaboratively by MS neurologists, to record data about COVID-19 infections in people with MS (pwMS). The objective of this… Continue Reading

In this single-center prospective case study the authors report patients with neurological autoimmunity in temporal association (≤6 weeks) with SARS-CoV-2 vaccinations and without other triggers.

In this article the authors examined the characteristics of COVID-19 severity in an international sample of people with MS.

In this article the authors aimed to determine the frequency and diagnostic features of COVID-19 related AE.

This study included prospective data from a large mental healthcare provider in London, UK, with deaths from 2019 to 2020, used to assess age and gender-standardised mortality ratios (SMRs) across nine psychiatric conditions and by ethnicity.